Episode 36: Chip Nash, Co-Founder and CEO of Crux
Medical innovation is moving faster than ever. But are employer healthcare benefits keeping up? In Episode 36 of Digital Health Heavyweights, Norm Volsky sits down with Chip Nash, Co-Founder and CEO of Crux, to explore why GLP-1 medications have exposed a much larger problem in employer-sponsored healthcare and how the next generation of breakthrough therapies could change the way employers fund, manage, and deliver benefits. With experience spanning Rally Health, Zephyr AI, and now Crux, Chip has spent his career tackling some of healthcare's most complex challenges. From building scalable digital health solutions to understanding the realities of provider workflows, he brings a unique perspective on why healthcare innovation often moves faster than the systems designed to support it. GLP-1 medications are just the beginning. As new treatments for obesity, cancer, Alzheimer's, and other conditions continue to emerge, employers will face increasingly difficult decisions about affordability, access, and how to support their workforce. Chip explains why traditional benefit and payment models aren't equipped to keep pace with these advances and how Crux is working to change that through a more flexible approach to healthcare financing. Rather than replacing existing clinical solutions, Crux is building the infrastructure to help employers and employees access innovative treatments while working alongside digital health partners. The conversation also explores how AI is transforming product development, why one-size-fits-all benefits strategies rarely work, and why greater collaboration across digital health could be essential to making healthcare more accessible. As Chip puts it: “We are not like heading there, we are sprinting toward there right now.” In this episode, you'll uncover: 💊 Why GLP-1 medications are exposing deeper challenges in employer healthcare financing 🚀 How breakthrough therapies could reshape the future of healthcare affordability and access 🔍 Why pricing transparency and better cost visibility matter for employers 💰 How combining employer and employee dollars could create more flexible benefit options 🤝 Why collaboration between digital health companies is critical to improving healthcare delivery 🧩 How Crux is building benefits infrastructure that supports existing clinical partners rather than replacing them 🤖 How AI is changing healthcare product development and accelerating innovation 🏢 Why employer healthcare strategies need to account for the unique needs of each workforce About Chip Nash: Chip Nash is the Co-Founder and CEO of Crux, a healthcare benefits infrastructure and transaction platform focused on creating more flexible ways for employers and employees to fund and access innovative treatments. Before founding Crux, Chip held leadership roles at Rally Health and Zephyr AI, gaining experience across digital health, healthcare technology, employer benefits, and AI-driven innovation. Through Crux, he is working to address the challenges surrounding GLP-1 access and build infrastructure that can support a broader range of healthcare benefits as new therapies emerge. Chapters: 00:00 Introduction to Chip Nash, Crux, and the Future of Employer Benefits 01:25 How an Accidental Start in Healthcare Led to Complex Problem-Solving 02:55 Lessons from Rally Health and Selling Capabilities Instead of Fear 06:14 Why Every Employer Needs a Different Healthcare Strategy 08:17 How AI Is Transforming Prototyping and Product Development 11:01 Lessons from Zephyr AI and the Challenges of Provider Software Adoption 14:06 Why GLP-1 Medications Inspired the Creation of Crux 16:55 Healthcare Pricing Transparency and Employer Cost Visibility 18:06 Why Breakthrough Therapies Require New Payment Models 20:17 Combining Employer and Employee Dollars for More Flexible Benefits 22:19 Why Digital Health Companies Need Greater Collaboration 23:23 How Crux Differs from Traditional GLP-1 Vendors and Marketplaces 25:28 Crux Partnerships with Flight, eMed, and Weight Watchers 28:54 Supporting Clinical Point Solutions Rather Than Replacing Them 32:21 Pharmacy Economics, Prior Authorization, and New Funding Models 36:44 Why Employers Are Ready to Challenge Hidden Healthcare Costs 39:15 The Unsustainable Economics of Employer-Sponsored Healthcare 41:42 Expanding Flexible Benefits Beyond Pharmacy and GLP-1s 45:21 Meditation, Walking, and Staying Healthy While Building a Company 46:40 Chip's Simple Chicken Recipe and Approach to Nutrition --- Follow, connect and subscribe: LinkedIn: https://www.linkedin.com/company/digital-health-heavyweights-podcast Youtube: https://youtube.com/@DigitalHealthHeavyweights Instagram: https://www.instagram.com/digitalhealthheavyweights/ TikTok: https://www.tiktok.com/@heavyweightspodcast






